Boehringer Ingelheim Aggrenox
Executive Summary
Dipyridimole and aspirin twice-daily capsules are deemed "approvable" June 15. Extended-release combination was recommended by an FDA advisory committee for reduction in risk of a secondary stroke, but not for reduction of mortality risk (1"The Pink Sheet" May 3, p. 9)